Gillian is an assistant editor for Pharmacy Times®.
House Committee Hearing Addresses PBMs, Anticompetitive Drug Pricing Tactics
The House Committee members examined pricing tactics by PBMs and how they are harming patients across the country.
Oncological Biosimilars Shown to Be as Safe as Their Reference Products
Study finds patients with cancer feel reassured that biosimilars provide a safe, adequate, and cost-effective alternative to the pricier reference drug.
2 Clarke Drive Cranbury, NJ 08512